Skip to main content

Herman Rosenman

Herman Rosenman has been appointed to the board of directors of DermTech. Rosenman was most recently CFO at Natera, from January 2014 to January 2017. Prior to that he was senior vice president of finance and CFO at Gen-Probe (now part of Hologic). He has also served as president and CEO of RadNet Management and CFO of Rexene.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.